Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

43.54
-0.4600-1.05%
Post-market: 43.610.0700+0.16%19:56 EDT
Volume:2.31M
Turnover:100.67M
Market Cap:7.24B
PE:-12.51
High:44.17
Open:44.17
Low:43.24
Close:44.00
52wk High:86.74
52wk Low:43.01
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.63
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:16.45
PE(LYR):-18.28

Loading ...

Ionis Pharmaceuticals, - Ulefnersen Demonstrates Favorable Safety and Tolerability Profile

THOMSON REUTERS
·
Sep 22

Ionis Pharmaceuticals, - Ulefnersen Demonstrates Statistically Significant Improvement on Primary Endpoint in Fus-ALS

THOMSON REUTERS
·
Sep 22

Ionis Announces Positive Topline Results from Phase 3 Fusion Study of Ulefnersen Marking Significant Milestone in Advancing First Potential Disease Modifying Treatment for Fus-ALS

THOMSON REUTERS
·
Sep 22

US Research Roundup-Boeing, Twilio, WP Carey

Reuters
·
Sep 22

Ionis Pharmaceuticals, Inc. : JP Morgan Cuts Target Price to $70 from $76

THOMSON REUTERS
·
Sep 22

Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today

TIPRANKS
·
Sep 22

Movement Alert|Ionis Pharmaceuticals Falls 5.01% in Regular Trading, Cardiovascular Pipeline Setbacks and Analyst Target Cuts Weigh on Shares

Market Focus
·
Sep 19

Movement Alert|Ionis Pharmaceuticals Rises 5.03% in Regular Trading, Trading at $45.87

Market Focus
·
Sep 17

Movement Alert|Ionis Pharmaceuticals Falls 5.25% in Regular Trading, Consecutive Cardiovascular Pipeline Failures Continue to Weigh on Shares

Market Focus
·
Sep 17

Movement Alert|Ionis Pharmaceuticals Falls 6.29% in Regular Trading, Continued Pressure from Consecutive Heart Disease Drug Trial Failures

Market Focus
·
Sep 16

Ionis Pharmaceuticals Price Target Cut to $80.00/Share from $89.00 by Guggenheim

Dow Jones
·
Sep 15

Ionis Pharmaceuticals price target lowered to $80 from $89 at Guggenheim

TIPRANKS
·
Sep 15

Guggenheim Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 15

BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93

MT Newswires Live
·
Sep 09

Bank of America Securities Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 09

U.S. Stocks on the MOVE-Best Buy, Peloton, Apple

Reuters
·
Sep 09

Ionis Pharmaceuticals price target lowered to $84 from $87 at Raymond James

TIPRANKS
·
Sep 09

Royalty Pharma Falls After Novartis' Cholesterol Drug Fails in Study

Reuters
·
Sep 09

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

Movement Alert|Ionis Pharmaceuticals Falls 7.76% in Regular Trading, Partner Novartis Lp(a) Drug Fails Phase 3 Trial

Market Focus
·
Sep 08